Adding intranasal treatment of BDQ and DLM in Infasurf to oral treatment with PRS regimen V reduced lung burden by an additional 0.4 logs, although this difference did not reach statistical significance.
← all excerpts
Adding Intranasal to Oral Administration of an Ultra-Rapid Near-Universal Drug Regimen Accelerates Relapse-Free Cure of Tuberculosis in Mice.
1
—
—